Concepts and targets in triple-negative breast cancer: recent results and clinical implications
Triple-negative breast cancer (TNBC) is a heterogeneous disease in which tumors are defined by lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) receptor. No targeted therapies are available for the treatment of...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
SAGE Publishing
2016-09-01
|
| Sarja: | Therapeutic Advances in Medical Oncology |
| Linkit: | https://doi.org/10.1177/1758834016657071 |